COMBINATION BIOLOGIC AND SMALL MOLECULE THERAPY FOR REFRACTORY ULCERATIVE COLITIS

被引：0
|
作者：
Hickman, Kaitlyn
Jordan, Ronald
Sonnier, William
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [31] Positioning biologic therapy for Crohn's disease and ulcerative colitis
    Velayos F.S.
    Sandborn W.J.
    Current Gastroenterology Reports, 2007, 9 (6) : 521 - 527
  • [32] Success of Cyclosporin and Tofacitinib Combination Therapy in a Patient With Severe Steroid-refractory Ulcerative Colitis
    Yang, Qinglu
    Chen, Liang
    Feng, Lijin
    Liu, Changqin
    Fang, Leilei
    Liu, Zhanju
    Sun, Xiaomin
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (12) : E157 - E158
  • [33] Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis
    Nakamura, Masanao
    Yamamura, Takeshi
    Maeda, Keiko
    Sawada, Tsunaki
    Mizutani, Yasuyuki
    Ishikawa, Eri
    Ohashi, Ayako
    Kajikawa, Go
    Furukawa, Kazuhiro
    Ohno, Eizaburo
    Honda, Takashi
    Kawashima, Hiroki
    Ishigami, Masatoshi
    Fujishiro, Mitsuhiro
    INTERNAL MEDICINE, 2020, 59 (23) : 3009 - 3014
  • [34] Tofacitinib in ulcerative colitis - Small molecule but large effect
    Harindranath, Sidharth
    Singh, Ankita
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (02) : 371 - 372
  • [35] Small molecule oral targeted therapies in ulcerative colitis
    Shivaji, Uday N.
    Nardone, Olga Maria
    Cannatelli, Rosanna
    Smith, Samuel Cl
    Ghosh, Subrata
    Iacucci, Marietta
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (09): : 850 - 861
  • [36] Need for surgery in patients with ulcerative colitis in the era of biologic therapy
    Zamora Olaya, J. M.
    Aparicio-Serrano, A.
    Gomez Perez, A.
    Ortiz Chimbo, D. S.
    Rodriguez Tirado, M. I.
    Soto Escribano, P.
    Marin Pedrosa, S.
    Iglesias Flores, E.
    Benitez, J. M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I467 - I467
  • [37] Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis
    Ganzleben, Ingo
    Hirschmann, Simon
    Naegel, Andreas
    Glueck, Christian
    Rath, Timo
    Neurath, Markus F.
    Gimped, Carol
    Osaba, Lourdes
    Nagore, Daniel
    Hoffman, Arthur
    Atree, Raje
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [38] Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis
    Sofia, M. Anthony
    Rubin, David T.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (04) : 548 - 559
  • [39] Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
    Pellet, Gauthier
    Stefanescu, Carmen
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    Allimant, Christophe
    Nachury, Maria
    Nancey, Stephane
    Filippi, Jerome
    Altwegg, Romain
    Brixi, Hedia
    Fotsing, Ginette
    de Rosamel, Laure
    Shili, Sarah
    Laharie, David
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 494 - 501
  • [40] Editorial: Is vedolizumab the preferred biologic therapy for biologic-naive patients with ulcerative colitis?
    Yamamoto, Takayuki
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (05) : 546 - 547
12345